National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; Ambulatory of Nutrition, IRCCS "S. de Bellis" National Institute of Gastroenterology-Research Hospital, Castellana Grotte, Bari, Italy.
Primary Care Department, Azienda USL Toscana Sud Est, Grosseto, Italy.
Clin Nutr. 2019 Jun;38(3):1101-1108. doi: 10.1016/j.clnu.2018.05.019. Epub 2018 Jun 1.
BACKGROUND & AIMS: The literature regarding the potential health benefits of chocolate consumption are unclear and the epidemiological credibility has not been systematically scrutinized, while the strength of the evidence is undetermined. We therefore aimed to map and grade the diverse health outcomes associated with chocolate consumption using an umbrella review of systematic reviews.
Umbrella review of systematic reviews of observational and intervention studies (randomized placebo-controlled trials, RCTs). For each association, random-effects summary effect size, 95% confidence interval, and 95% prediction interval were estimated. We also assessed heterogeneity, evidence for small-study effect and evidence for excess significance bias. For significant outcomes of the RCTs, the GRADE assessment was furtherly used.
From 240 articles returned, 10 systematic reviews were included (8 of which included a meta-analysis), including a total of 84 studies (36 prospective observational studies and 48 interventional). Nineteen different outcomes were included. Among observational studies, including a total of 1,061,637 participants, the best available evidence suggests that chocolate consumption is associated with reduced risk of cardiovascular disease (CVD) death (n = 4 studies), acute myocardial infarction (n = 6), stroke (n = 5) and diabetes (n = 6), although this was based on a weak evidence of credibility. Across meta-analyses of intervention studies, chocolate consumption was positively associated with flow-mediated dilatation at 90-150 min (n = 3) and at 2-18 weeks (n = 3), and insulin resistance markers (n = 2). However, using the GRADE assessment, the evidence for these outcomes was low or very low. Data from two systematic reviews, reported that chocolate consumption was not associated with better depressive mood or cognitive function.
There is weak evidence to suggest that chocolate consumption may be associated with favorable health outcomes.
巧克力消费潜在健康益处的相关文献尚不清楚,其流行病学可信度也尚未得到系统审查,而证据的力度也尚未确定。因此,我们旨在通过系统综述的伞式审查来绘制和评估与巧克力消费相关的各种健康结果,并对其进行分级。
对观察性和干预性研究(随机安慰剂对照试验,RCT)的系统综述进行伞式审查。对于每种关联,我们估计了随机效应汇总效应大小、95%置信区间和 95%预测区间。我们还评估了异质性、小样本研究效应的证据和过度显著性偏差的证据。对于 RCT 的显著结果,我们进一步使用 GRADE 评估。
从 240 篇返回的文章中,纳入了 10 篇系统综述(其中 8 篇包含荟萃分析),共纳入了 84 项研究(36 项前瞻性观察性研究和 48 项干预性研究)。纳入了 19 种不同的结果。在观察性研究中,共有 1061637 名参与者,最佳现有证据表明,巧克力消费与降低心血管疾病(CVD)死亡风险(n=4 项研究)、急性心肌梗死(n=6 项研究)、中风(n=5 项研究)和糖尿病(n=6 项研究)有关,尽管这是基于可信度较弱的证据。在干预性研究的荟萃分析中,巧克力消费与 90-150 分钟(n=3)和 2-18 周(n=3)的血流介导的扩张以及胰岛素抵抗标志物(n=2)呈正相关。然而,使用 GRADE 评估,这些结果的证据质量较低或极低。两篇系统综述的数据报告称,巧克力消费与改善抑郁情绪或认知功能无关。
有微弱的证据表明,巧克力消费可能与更有利的健康结果相关。